ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0R3M Vivoryon Therapeutics Nv

4.71
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 20162017201820192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 22.37M10.76M4.05M45.46M29.75M24.52M31.38M30.83M
Total Current Assets 22.2M10.69M3.98M45.38M28.79M20.23M30.69M29.81M
Cash and Equivalents 21.78M10.19M3.68M41.42M26.31M14.66M26.56M18.56M
Total Non-Current Assets 16.85M9.25M1.54M43.04M26.22M16.56M26.51M26.28M
Total Liabilities 5.52M1.52M2.51M2.42M3.53M7.96M4.87M4.55M
Total Current Liabilities 1.58M251k581k526k1.33M5.05M3.27M3.18M
Total Non-Current Liabilities 3.94M1.26M1.92M1.9M2.43M3.04M1.65M1.37M
Total Equity 16.85M9.25M1.54M43.04M26.22M16.56M26.51M26.28M
Common Equity 8.19M8.21M8.21M19.98M19.98M20.05M24.11M26.07M
Retained Earnings -40.58M-48.31M-56.01M-65.76M-79.65M-92.3M-120.46M-148.8M